Crowdfunding appeal to help autism research

NeuroPointDX, a division of Madison-based Stemina Biomarker Discovery, is developing a blood test that can provide earlier diagnosis and more precise treatment of Autism spectrum disorder (ASD) through its clinical study, based on the child’s own metabolism.

From a story in the Wisconsin State Journal, the company has launched a public crowdfunding campaign to raise $50,000 to help fund its Children’s Autism Metabolome Project (CAMP).

For more information about the company, the study, or to donate, click here.